Question · Q4 2025
Shlomo Rosenbaum, Managing Director at Stifel, asked for more detail on WM's optimistic view of the healthy economy, requesting specific metrics like service interval trends, scale reports on mature routes, residential scale reports, and temporary roll-off activity. He also followed up on the suspension of pricing initiatives in Healthcare Solutions, asking if the Q1 2026 target for resolution is on track and if the issues preventing pricing have been addressed.
Answer
CEO Jim Fish cited a good pipeline in special waste and strong temporary roll-off activity as leading indicators for an optimistic economic outlook, noting that the C&D business grew 3.4% for the year. Regarding Healthcare Solutions pricing, Jim Fish clarified that while some price increases were suspended, the main issue was dilution from credit memos, which are believed to have peaked in Q4 2025 and are now on a downward trend, providing a tailwind for 2026 through less dilution rather than new price execution.
Ask follow-up questions
Fintool can predict
WM's earnings beat/miss a week before the call

